ROYAL BANK OF CANADA - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 90 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 15.12 and the average weighting 0.3%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$16,000
-73.8%
3,238
-43.2%
0.00%
Q4 2019$61,000
+96.8%
5,699
+90.0%
0.00%
Q3 2019$31,000
-34.0%
3,000
-1.5%
0.00%
Q2 2019$47,000
+20.5%
3,047
+1.4%
0.00%
Q1 2019$39,000
+34.5%
3,004
+0.1%
0.00%
Q4 2018$29,000
-53.2%
3,000
-20.3%
0.00%
Q3 2018$62,000
+24.0%
3,766
+19.8%
0.00%
Q2 2018$50,000
+8.7%
3,144
+4.7%
0.00%
Q1 2018$46,000
-16.4%
3,003
-14.2%
0.00%
Q4 2017$55,000
-1.8%
3,500
-31.2%
0.00%
Q3 2017$56,000
+93.1%
5,089
+63.9%
0.00%
Q2 2017$29,000
-9.4%
3,104
-17.2%
0.00%
Q1 2017$32,000
-25.6%
3,747
-6.0%
0.00%
Q4 2016$43,0003,985
+6030.8%
0.00%
Q4 2015$0
-100.0%
65
-90.4%
0.00%
Q3 2015$6,000
-40.0%
679
-23.9%
0.00%
Q2 2015$10,000892
+11050.0%
0.00%
Q4 2014$0
-100.0%
8
-85.5%
0.00%
Q3 2013$2,000550.00%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Lyon Street Capital, LLC 762,941$7,248,0007.29%
NEXTHERA CAPITAL LP 711,558$6,760,0002.79%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 585,930$4,366,0002.71%
Consonance Capital Management LP 1,155,793$10,980,0000.81%
Pier Capital, LLC 423,667$4,025,0000.80%
KNOTT DAVID M 155,795$1,480,0000.70%
Eventide Asset Management 1,086,400$10,321,0000.46%
Empire Life Investments Inc. 373,863$3,552,0000.32%
Telemetry Investments, L.L.C. 41,588$395,0000.25%
Polar Capital LLP 2,302,666$21,875,0000.23%
View complete list of STEMLINE THERAPEUTICS INC shareholders